Certain specific MRI features [enhancement quality (F4), tumor-enhancing proportion (F5), tumor–non-enhancing proportion (F6), and necrosis proportion (F7)] have been shown in our previously published study (21) to be predictive of the grade and IDH status of gliomas, with significant prognostic implications. The gene discussed is IDH2; the disease is glioma.